NOVARTIS FDA Approval NDA 020036

NDA 020036

NOVARTIS

FDA Drug Application

Application #020036

Documents

Letter2004-09-10
Letter1998-09-22
Letter1998-09-22
Letter2002-07-12
Letter2004-03-28
Letter2005-02-03
Letter2005-10-14
Letter2005-11-18
Letter2011-04-04
Label2001-08-20
Label2005-02-03
Label2005-10-14
Label2005-11-18
Label2007-12-14
Label2009-01-02
Label2012-06-06
Review2004-01-06
Review2004-01-06
Review2004-01-06
Review2008-02-19
Review2004-05-27
Review2007-08-06
Letter2003-12-02
Letter2003-10-16
Letter2001-08-20
Letter2004-01-09
Letter2008-01-09
Letter2008-12-18
Letter2012-06-07
Other Important Information from FDA2008-01-07
Label2003-12-02
Label2003-04-30
Label2011-04-11
Review2004-01-06
Review2004-01-06
Review2004-01-06
Review1998-09-22
Review1998-09-22
Review2009-01-12

Application Sponsors

NDA 020036NOVARTIS

Marketing Status

Discontinued001
Discontinued003
Discontinued004

Application Products

001INJECTABLE;INJECTION30MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1AREDIAPAMIDRONATE DISODIUM
003INJECTABLE;INJECTION60MG/VIAL0AREDIAPAMIDRONATE DISODIUM
004INJECTABLE;INJECTION90MG/VIAL0AREDIAPAMIDRONATE DISODIUM

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1991-10-31PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1993-05-06PRIORITY
LABELING; LabelingSUPPL3AP1992-07-21PRIORITY
EFFICACY; EfficacySUPPL4AP1994-04-15PRIORITY
LABELING; LabelingSUPPL5AP1993-06-09PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1995-04-17PRIORITY
EFFICACY; EfficacySUPPL7AP1994-09-21PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1994-12-08PRIORITY
EFFICACY; EfficacySUPPL9AP1995-09-01PRIORITY
EFFICACY; EfficacySUPPL11AP1996-07-16PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1998-10-05PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1998-09-10PRIORITY
LABELING; LabelingSUPPL15AP1998-09-22PRIORITY
LABELING; LabelingSUPPL16AP1998-09-22PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL18AP2000-04-28PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL19AP2000-03-31PRIORITY
LABELING; LabelingSUPPL20AP2003-10-09PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL21AP2001-03-07PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL22AP2002-01-03PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL23AP2001-11-15PRIORITY
EFFICACY; EfficacySUPPL24AP2001-08-20PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL25AP2002-02-12PRIORITY
EFFICACY; EfficacySUPPL26AP2002-07-12PRIORITY
LABELING; LabelingSUPPL28AP2004-01-09PRIORITY
LABELING; LabelingSUPPL29AP2004-03-24PRIORITY
LABELING; LabelingSUPPL30AP2005-02-02PRIORITY
LABELING; LabelingSUPPL31AP2005-10-11PRIORITY
LABELING; LabelingSUPPL32AP2005-11-16PRIORITY
LABELING; LabelingSUPPL34AP2007-12-11PRIORITY
LABELING; LabelingSUPPL35AP2008-12-12PRIORITY
LABELING; LabelingSUPPL39AP2011-04-07PRIORITY
LABELING; LabelingSUPPL41AP2012-05-31PRIORITY

Submissions Property Types

ORIG1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL9Null0
SUPPL11Null0
SUPPL13Null0
SUPPL14Null0
SUPPL15Null0
SUPPL16Null0
SUPPL18Null0
SUPPL19Null0
SUPPL20Null0
SUPPL21Null0
SUPPL22Null0
SUPPL23Null0
SUPPL24Null0
SUPPL25Null0
SUPPL26Null0
SUPPL28Null0
SUPPL29Null0
SUPPL30Null0
SUPPL31Null0
SUPPL32Null0
SUPPL34Null0
SUPPL35Null0
SUPPL39Null0
SUPPL41Null0

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20036
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.